ArticleIn vivo (Athens, Greece)

Impact of PD-L1 Expression on the Overall Survival of Patients With Non-small Cell Lung Cancer Treated With Single-agent Pembrolizumab.

Martin Svaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.